Molecular modeling of blood-brain barrier nutrient transporters: In silico basis for evaluation of potential drug delivery to the central nervous system

被引:34
作者
Allen, DD [1 ]
Geldenhuys, WJ [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX 79106 USA
关键词
computer modeling; P-glycoprotein; choline transporter; CHT; OCT;
D O I
10.1016/j.lfs.2005.06.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
For drugs that act in the brain, the blood-brain barrier (BBB) is a considerable physical barrier which influences the distribution of drugs to the brain. The BBB is essentially impermeable for hydrophilic and/or charged compounds. Nutrient membrane transporters have an important physiological role in the transport of essential substances across the BBB required for normal brain function. We and others have shown that these transporters may have utility as drug delivery vectors, thereby increasing brain distribution of these compounds via these systems. In this review, we evaluate molecular (in silico) models of BBB transport proteins. Few BBB membrane transporters have been crystallized, but their crystal structures have a possibility for use in homology modeling. Other techniques commonly used are 2D quantitative structure-activity relationships (QSAR), as well as 3D-QSAR techniques including comparative molecular field analysis (CoMFA) and comparative similarity index analysis (CoMSIA). Each of these models provides valuable information for ascertaining their potential basis for BBB transport and brain drug delivery. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1029 / 1033
页数:5
相关论文
共 34 条
[1]   The blood-brain barrier choline transporter as a brain drug delivery vector [J].
Allen, DD ;
Lockman, PR .
LIFE SCIENCES, 2003, 73 (13) :1609-1615
[2]   MORPHOLOGY OF BLOOD-BRAIN INTERFACES [J].
BRIGHTMAN, MW .
EXPERIMENTAL EYE RESEARCH, 1977, 25 :1-25
[3]   In silico strategies for modeling membrane transporter function [J].
Chang, C ;
Ray, A ;
Swaan, P .
DRUG DISCOVERY TODAY, 2005, 10 (09) :663-671
[4]   In silico prediction of blood-brain barrier permeation [J].
Clark, DE .
DRUG DISCOVERY TODAY, 2003, 8 (20) :927-933
[5]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[6]   Structures and models of transporter proteins [J].
Dahl, SG ;
Sylte, I ;
Ravna, AW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03) :853-860
[7]  
DeLano W. L., 2004, PYMOL MOL GRAPHICS S
[8]  
Dwyer Donard S, 2003, Methods Mol Biol, V227, P335, DOI 10.1385/1-59259-387-9:335
[9]   Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein [J].
Ekins, S ;
Kim, RB ;
Leake, BF ;
Dantzig, AH ;
Schuetz, EG ;
Lan, LB ;
Yasuda, K ;
Shepard, RL ;
Winter, MA ;
Schuetz, JD ;
Wikel, JH ;
Wrighton, SA .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :964-973
[10]   Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates [J].
Ekins, S ;
Kim, RB ;
Leake, BF ;
Dantzig, AH ;
Schuetz, EG ;
Lan, LB ;
Yasuda, K ;
Shepard, RL ;
Winter, MA ;
Schuetz, JD ;
Wikel, JH ;
Wrighton, SA .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :974-981